About Lankenau Institute for Medical Research
It operates as a HealthTech. Lankenau Institute for Medical Research offers products and services including Cancer Research, Cardiovascular Disease Research, and Clinical Research.
Products & Services of Lankenau Institute for Medical Research
Lankenau Institute for Medical Research offers a comprehensive portfolio of products and services, including Cancer Research, Cardiovascular Disease Research, and Clinical Research.
Research on cancer treatments is conducted for advancements.
Cardiovascular disease solutions are developed through dedicated research.
Clinical issues are explored through structured research programs.
Apps and channels of Lankenau Institute for Medical Research
its YouTube channel Main Line Health has 5.7K subscribers and 30 videos.
Videos from Lankenau Institute for Medical Research
The most watched videos on Lankenau Institute for Medical Research's YouTube channel, Main Line Health (5.7K subscribers). Click a video to play it here.
More on Main Line Health.
Similar companies to Lankenau Institute for Medical Research
10 companies that operate in the same segment as Lankenau Institute for Medical Research (Immunology & Cancer Therapeutics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | – | – | |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Targeted therapies for cancer treatment are developed. | 2005 | Waltham, Massachusetts, United States | USD 198.29 M | USD 172.35 M | 270 | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Plasma-based biologics are developed for immune deficiency and infectious diseases. | 2005 | Ramsey, Minnesota, United States | USD 17.55 M | USD 510.17 M | 685 | |
Antibody drugs for cancer treatment are developed. | 2015 | Singapore, Singapore | USD 150 M | – | – | |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | 2003 | United States | USD 171.85 M | USD 102.48 M | 338 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lankenau Institute for Medical Research
Research on cancer, cardiovascular, autoimmune, and gastrointestinal diseases is conducted by the Lankenau Institute for Medical Research. Focus is placed on immunotherapy and innovative healthcare solutions. Programs include clinical research and technology development for translating discoveries into patient care. Sectors covered include regenerative medicine and biotech incubation. Efforts are led to create groundbreaking advances in medical treatments.
Lankenau Institute for Medical Research offers Cancer Research, Cardiovascular Disease Research, and Clinical Research.